Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2025-12-25 @ 12:37 AM
NCT ID:
NCT01763567
Brief Summary:
The purpose of this study is to assess safety and device performance of the Medtronic Hospital Glucose Management System (HGMS) for up to 72-hours.
Detailed Description:
Assess safety and device performance of the Medtronic HGMS in the critically-ill setting and analyze the following:
1. Device Performance:
* Functionality of HGMS
* Alerts/Alarms Specificity and Sensitivity
* System Workflow
2. Safety:
* Descriptive statistics will be used to characterize safety events
* Moderate and severe anticipated device and procedure related adverse events
* All serious adverse events and unanticipated adverse device effects related events
Study:
NCT01763567
Study Brief:
Protocol Section:
NCT01763567